Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125081822 | 12508182 | 2 | F | 20160520 | 20160623 | 20160629 | 20160705 | EXP | CH-PFIZER INC-2016315220 | PFIZER | 68.00 | YR | F | Y | 0.00000 | 20160705 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125081822 | 12508182 | 1 | PS | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | 2080 | MG | 20987 | 40 | MG | PROLONGED-RELEASE TABLET | |||||
| 125081822 | 12508182 | 2 | SS | DAFALGAN | ACETAMINOPHEN | 1 | Oral | 1 G, 4X/DAY | 28 | G | 0 | 1 | G | FILM-COATED TABLET | QID | ||||
| 125081822 | 12508182 | 3 | SS | ZYLORIC | ALLOPURINOL | 1 | Oral | 300 MG, 1X/DAY | 0 | 300 | MG | TABLET | QD | ||||||
| 125081822 | 12508182 | 4 | C | DUROGESIC | FENTANYL | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 5 | C | LYRICA | PREGABALIN | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 6 | C | PREDNISON | PREDNISONE | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 7 | C | TEMESTA /00273201/ | LORAZEPAM | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 8 | C | FRAGMIN | DALTEPARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 9 | C | MORPHIN /00036303/ | MORPHINE | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 10 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 11 | C | NOVALGIN | METAMIZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 12 | C | FORTECORTIN /00016001/ | DEXAMETHASONE | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 13 | C | MOTILIUM | DOMPERIDONE | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 14 | C | CIPROXIN /00697201/ | CIPROFLOXACIN | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 15 | C | CEFAZOLIN | CEFAZOLIN | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 16 | C | THIOPENTHAL | 2 | UNK | 0 | ||||||||||||
| 125081822 | 12508182 | 17 | C | DORMICUM /00634101/ | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 18 | C | TIENAM | CILASTATIN SODIUMIMIPENEM | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 19 | C | IBUPROFEN. | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 20 | C | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 21 | C | CO-AMOXI | AMOXICILLINCLAVULANATE POTASSIUM | 1 | UNK | 0 | |||||||||||
| 125081822 | 12508182 | 22 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125081822 | 12508182 | 1 | Duodenogastric reflux |
| 125081822 | 12508182 | 2 | Pain |
| 125081822 | 12508182 | 3 | Gout |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125081822 | 12508182 | OT |
| 125081822 | 12508182 | DE |
| 125081822 | 12508182 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125081822 | 12508182 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125081822 | 12508182 | 1 | 20160330 | 20160523 | 0 | |
| 125081822 | 12508182 | 2 | 20160514 | 20160523 | 0 | |
| 125081822 | 12508182 | 3 | 20160330 | 0 |